Feb 25, 2025 / 10:00PM GMT
Christopher Richards - Apiam Animal Health Ltd - Managing Director, Executive Director
Apiam Animal Health first half results call for 2025, results. I'm Chris Richards, managing director, and today I'll be joined by, Matt White, who's our CFO.
Let's start off with just a summary on the results, and you can see from the results they're very consistent with what we reported at our AGM in in late November. Although we did have a stronger, a strong revenue in December.
A revenue of $106.2 million was, up 1.7% on the prior comparative year. Gross profit was, up 0.1%, mainly due to the contribution of the intensive animals, which is, at a lower margin. I'll talk to that later.
Our, underlying, EBITDA pre-ASB 16 of $10.8 million, was, relatively in line with the prior comparative, period. Our MPAA, underlying MPAA of $3.9 million was 15.5%. That'll talked to that a little bit later in relation to the impact of our right of use depreciation interest that had an impact on that.
The reported NAT of, was negative $1.5 million, and that was, because of an impairment that we've
Half Year 2025 Apiam Animal Health Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
